622 related articles for article (PubMed ID: 19233898)
1. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
Doumith M; Ellington MJ; Livermore DM; Woodford N
J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898
[TBL] [Abstract][Full Text] [Related]
2. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory.
Woodford N; Dallow JW; Hill RL; Palepou MF; Pike R; Ward ME; Warner M; Livermore DM
Int J Antimicrob Agents; 2007 Apr; 29(4):456-9. PubMed ID: 17293088
[TBL] [Abstract][Full Text] [Related]
3. Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp.
Jaskulski MR; Medeiros BC; Borges JV; Zalewsky R; Fonseca ME; Marinowic DR; Rocha MP; Nodari P; Machado DC
Int J Antimicrob Agents; 2013 Jul; 42(1):76-9. PubMed ID: 23664677
[TBL] [Abstract][Full Text] [Related]
4. Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital.
Yang FC; Yan JJ; Hung KH; Wu JJ
J Clin Microbiol; 2012 Feb; 50(2):223-6. PubMed ID: 22135256
[TBL] [Abstract][Full Text] [Related]
5. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
[TBL] [Abstract][Full Text] [Related]
6. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
[TBL] [Abstract][Full Text] [Related]
7. Role of association of OmpK35 and OmpK36 alteration and bla
Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital.
Chung HS; Yong D; Lee M
J Investig Med; 2016 Jun; 64(5):1042-9. PubMed ID: 27101841
[TBL] [Abstract][Full Text] [Related]
9. Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones.
Novais A; Rodrigues C; Branquinho R; Antunes P; Grosso F; Boaventura L; Ribeiro G; Peixe L
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3057-63. PubMed ID: 22706513
[TBL] [Abstract][Full Text] [Related]
10. Clonality, outer-membrane proteins profile and efflux pump in KPC- producing Enterobacter sp. in Brazil.
Rosa JF; Rizek C; Marchi AP; Guimaraes T; Miranda L; Carrilho C; Levin AS; Costa SF
BMC Microbiol; 2017 Mar; 17(1):69. PubMed ID: 28302074
[TBL] [Abstract][Full Text] [Related]
11. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results.
Carvalhaes CG; Picão RC; Nicoletti AG; Xavier DE; Gales AC
J Antimicrob Chemother; 2010 Feb; 65(2):249-51. PubMed ID: 19996141
[TBL] [Abstract][Full Text] [Related]
12. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
[TBL] [Abstract][Full Text] [Related]
13. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
14. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.
Poulou A; Voulgari E; Vrioni G; Koumaki V; Xidopoulos G; Chatzipantazi V; Markou F; Tsakris A
J Clin Microbiol; 2013 Oct; 51(10):3176-82. PubMed ID: 23850951
[TBL] [Abstract][Full Text] [Related]
15. The differential importance of mutations within AmpD in cephalosporin resistance of Enterobacter aerogenes and Enterobacter cloacae.
Babouee Flury B; Ellington MJ; Hopkins KL; Turton JF; Doumith M; Woodford N
Int J Antimicrob Agents; 2016 Nov; 48(5):555-558. PubMed ID: 27665520
[TBL] [Abstract][Full Text] [Related]
16. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.
Landman D; Bratu S; Quale J
J Med Microbiol; 2009 Oct; 58(Pt 10):1303-1308. PubMed ID: 19556371
[TBL] [Abstract][Full Text] [Related]
17. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China.
Zhou T; Zhang X; Guo M; Ye J; Lu Y; Bao Q; Chi W
Jpn J Infect Dis; 2013; 66(2):96-102. PubMed ID: 23514904
[TBL] [Abstract][Full Text] [Related]
19. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
20. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
